LatestHeadlines

Sign In

Sign In

Sign In

GLP-1

Wegovy maker Novo Nordisk to reduce costs after US$95bil stock loss

Wegovy maker Novo Nordisk to reduce costs after US$95bil stock loss

US plans Medicare, Medicaid coverage for weight-loss drugs

US plans Medicare, Medicaid coverage for weight-loss drugs

Australia to ban knock-offs of weight-loss drugs Ozempic, Mounjaro

Australia to ban knock-offs of weight-loss drugs Ozempic, Mounjaro

EU’s drug regulator finds no link between weight-loss drugs, suicidal thoughts

EU’s drug regulator finds no link between weight-loss drugs, suicidal thoughts

EU watchdog to seek data from drugmakers over suicidal thoughts

EU watchdog to seek data from drugmakers over suicidal thoughts

Pfizer to end clinical trial of weight loss pill amid high side effect rates

Pfizer to end clinical trial of weight loss pill amid high side effect rates